Patent details

Basic Information

Publication number:

EP1323431

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP030033161

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels

French Title of Invention:

Composition pour l' administration percutanée et/ou par voie transmucosale de principes actifs assurant des niveaux d' efficacité thérapeutiques adéquats

German Title of Invention:

Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert

SPC Number:

Dates

Filing date:

03/08/2001

Grant date:

27/10/2010

EP Publication Date:

27/10/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/07/2003

EP B1 Publication Date:

27/10/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/08/2011

Expiration date:

03/08/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/08/2001

 

 

Name:

Antares Pharma IPL AG

Address:

Treuhand von Flue AG, Baarerstrasse 95, 6301 Zug, Switzerland (CH)

Inventor

1

Name:

Rodriguez Jorge, c/o Antares Pharma AG

Address:

Switzerland (CH)

2

Name:

Carrara Dario, c/o Antares Pharma AG

Address:

Switzerland (CH)

3

Name:

Porto Gabriel, c/o Antares Pharma AG

Address:

Switzerland (CH)

Priority

Priority Number:

07533

Priority Date:

03/08/2000

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 47/10;

Filing date	Document type	Number of pages